Tuberculosis Diagnostic Market– Industry Structure Evaluation, Demand Drivers Analysis, Regional Growth Analysis and Identification, Competitive Positioning Review & Global Market Size Forecast to 2029
Overview
Tuberculosis Diagnostic Market is expected to grow at a CAGR of 4.82% during the forecast period. Global Tuberculosis Diagnostic Market is expected to reach US$ 4.86 Bn. by 2029.
Global Tuberculosis Diagnostic Market Overview:
Tuberculosis or TB is an infectious disease caused by Mycobacterium tuberculosis bacteria. Tuberculosis generally affects the lungs, but can also affect other parts of the body. Most infections do not have symptoms and this is known as latent tuberculosis. About 10% of latent infections progress to active disease which, if left untreated, kills about half of those infected.
Tuberculosis Diagnostic Market Snapshot
To Know About The Research Methodology :- Request Free Sample Report
Global Tuberculosis Diagnostic Market Dynamics:
Rising Burden of Tuberculosis and Multi-drug Resistant Tuberculosis (MDR TB) are the primary factors driving the market growth.
According to the World Health Organization (WHO), about 10 million people are affected by tuberculosis, each year. Further, tuberculosis is the leading cause of death from a single infectious agent, ranking above HIV/AIDS. The rise in initiatives by governments and independent organizations to control the spread of tuberculosis is also contributing to the growth of the global tuberculosis diagnostics market. An increase in expenditure on R&D activities for the development of novel tuberculosis diagnostic procedures will be a major factor for the growth of the tuberculosis diagnostics market growth in the forecast period. However, the high cost associated with the Tuberculosis testing procedure may hamper the market growth.
The report has profiled fifteen key players in the market from different regions. However, report has considered all market leaders, followers and new entrants with investors while analyzing the market and estimation the size of the same. Increasing R&D activities in each region are different and focus is given on the regional impact on the cost, availability of advanced technology are analyzed and report has come up with recommendations for future hot spot in APAC region.
Global Tuberculosis Diagnostic Market Segment Analysis:
The Global Tuberculosis Diagnostic Market is segmented on the basis of Test Type and End-users.
Based on Test Type, the Nucleic Acid Testing segment is projected to hold a significant market share. Nucleic acid testing of tuberculosis provides a higher level of accuracy and higher speed than culture-based tests, which is a factor driving the growth of the nucleic acid testing segment. The segment is expected to witness a CAGR of 5.4% over the forecast years.
Tuberculosis Diagnostic Market, by Test Type in 2022 (%)
Global Tuberculosis Diagnostic Market Regional Insights:
Asia Pacific is expected to witness lucrative market growth during forecast period.
Due to the high burden of tuberculosis as well as the rapid proliferation of this disease the region is expected to dominate the market. Countries, such as India, China, Indonesia, and Afghanistan are among the top-priority countries for the control of communicable diseases, according to the WHO. China and India registered the highest number of new cases of tuberculosis annually, followed by African and Latin American countries.
The report also helps in understanding Global Market dynamics, structure by analyzing the market segments and project the Global Market size. Clear representation of competitive analysis of key players by product, price, financial position, product portfolio, growth strategies, and regional presence in the Global Market make the report investor’s guide.
Key Developments:
In June 2018, Qiagen set up new guidelines from the American Academy of Pediatrics (AAP) for screening children as young as two years old, for latent tuberculosis infection.
Global Tuberculosis Diagnostic Market Scope: Inquire before buying
| Global Tuberculosis Diagnostic Market | |||
|---|---|---|---|
| Report Coverage | Details | ||
| Base Year: | 2022 | Forecast Period: | 2023-2029 |
| Historical Data: | 2018 to 2022 | Market Size in 2022: | US $ 3.49 Bn. |
| Forecast Period 2023 to 2029 CAGR: | 4.82% | Market Size in 2029: | US $ 4.86 Bn. |
| Segments Covered: | by Test Type | Radiographic Test Nucleic Acid Testing Cytokine Detection Test Other |
|
| by End users | Hospital/Clinics Diagnostics/Research Laboratory Other |
||
Global Tuberculosis Diagnostic Market, by Region
North America (United States, Canada and Mexico)
Europe (UK, France, Germany, Italy, Spain, Sweden, Austria, Turkey, Russia and Rest of Europe)
Asia Pacific (China, India, Japan, South Korea, Australia, ASEAN and Rest of APAC)
Middle East and Africa (South Africa, GCC, Egypt, Nigeria and Rest of ME&A)
South America (Brazil, Argentina, Columbia and Rest of South America)
Global Tuberculosis Diagnostic Market, Key Players are
1. Thermo Fisher Scientific, Inc.
2. Alere, Inc.
3. Becton
4. Dickinson and Company
5. F. Hoffmann-La Roche AG
6. LIONEX Diagnostics & Therapeutics GmbH
7. Danaher Corporation
8. Creative Diagnostics
9. QIAGEN
10. Oxford Immunotec Ltd.
11. Hologic, Inc.
12. Cepheid
13. Akonni Biosystems, Inc.
14. bioMerieux SA
15. Epistem Ltd.
Frequently Asked Questions:
1. Which region has the largest share in Global Tuberculosis Diagnostic Market?
Ans: Asia Pacific region holds the highest share in 2022.
2. What is the growth rate of Global Tuberculosis Diagnostic Market?
Ans: The Global Tuberculosis Diagnostic Market is growing at a CAGR of 4.82% during forecasting period 2023-2029.
3. What is scope of the Global Tuberculosis Diagnostic market report?
Ans: Global Tuberculosis Diagnostic Market report helps with the PESTEL, PORTER, COVID-19 Impact analysis, Recommendations for Investors & Leaders, and market estimation of the forecast period.
4. Who are the key players in Global Tuberculosis Diagnostic market?
Ans: The important key players in the Global Market are – Thermo Fisher Scientific, Inc., Alere, Inc., Becton, Dickinson and Company, F. Hoffmann-La Roche AG, LIONEX Diagnostics & Therapeutics GmbH, Danaher Corporation, Creative Diagnostics, QIAGEN, Oxford Immunotec Ltd., Hologic, Inc., Cepheid, Akonni Biosystems, Inc., bioMerieux SA, and Epistem Ltd.
5. What is the study period of this market?
Ans: The Global Market is studied from 2022 to 2029